Renal - Renal Replacement Therapy
- Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
- Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW.
- Am J Kidney Dis. 2012 Jun;59(6):810-8.
Rationale for inclusion: Citrate is associated with decreased bleeding in patients requiring CRRT.
Citations - 126 (as of July 2017)
- Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury.
- Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
- J Crit Care. 2009 Mar;24(1):129-40.
Rationale for inclusion: Delayed initiation of RRT is associated with increased mortality, longer duration of RRT, LOS and dialysis dependence.
Citations - 289 (as of July 2017)
- Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
- Lins RL, Elseviers MM, Van der Niepen P, Hoste E, Malbrain ML, Damas P, Devriendt J; SHARF investigators.
- Nephrol Dial Transplant. 2009 Feb;24(2):512-8.
Rationale for inclusion: RCT: No difference in mortality between HD and CRR.
Citations - 218 (as of July 2017)
- Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis.
- Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL.
- Am J Kidney Dis. 2008 Aug;52(2):272-84.
Rationale for inclusion: Meta-analysis: Improved survival in early RRT.
Citations - 268 (as of July 2017)
- Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure.
- Bell M; SWING, Granath F, Schön S, Ekbom A, Martling CR.
- Intensive Care Med. 2007 May;33(5):773-80.
Rationale for inclusion: Improved renal recovery in CRRT compared to IHD. No difference in mortality.
Citations - 209 (as of July 2017)
- Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial.
- Vinsonneau C1, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF; Hemodiafe Study Group.
- Lancet. 2006 Jul 29;368(9533):379-85.
Rationale for inclusion: No difference in mortality between HD and CRRT in patients with MOF.
Citations - 607 (as of July 2017)
- Survival and quality of life of patients requiring acute renal replacement therapy.
- Ahlström A, Tallgren M, Peltonen S, Räsänen P, Pettilä V.
- Intensive Care Med. 2005 Sep;31(9):1222-8.
Rationale for inclusion: Long term outcomes in ICU patients with ARF.
Citations - 163 (as of July 2017)
- A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.
- Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM; Collaborative Group for Treatment of ARF in the ICU.
- Kidney Int. 2001 Sep;60(3):1154-63.
Rationale for inclusion: No difference in mortality between HD and CRRT.
Citations - 631 (as of July 2017)
- Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial.
- John S, Griesbach D, Baumgärtel M, Weihprecht H, Schmieder RE, Geiger H.
- Nephrol Dial Transplant. 2001 Feb;16(2):320-7.
Rationale for inclusion: Better hemodynamics but no difference in organ perfusion with CVVH compared to IHD.
Citations - 153 (as of July 2017)
- Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
- Tan HK, Baldwin I, Bellomo R.
- Intensive Care Med. 2000 Nov;26(11):1652-7.
Rationale for inclusion: No need for anticoagulation on CRRT in high-risk patients.
Citations - 163 (as of July 2017)
- Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial.
- Ronco C1, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G.
- Lancet. 2000 Jul 1;356(9223):26-30.
Rationale for inclusion: Higher doses of CVVH were associated with improved early mortality.
Citations - 1817 (as of July 2017)
- Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure.
- Davenport A, Will EJ, Davidson AM.
- Crit Care Med. 1993 Mar;21(3):328-38.
Rationale for inclusion: Improved hemodynamics tolerance in CRRT compared to IHD in patients with impaired oxygen delivery.
Citations - 308 (as of July 2017)